- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03299491
An Implementation Study of Interventions to Promote Safe Motherhood in Jimma Zone Ethiopia
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
A three-arm cluster trial design will be used to measure the impact of the intervention packages in three districts (Gomma, Seka Chekorsa, Kersa) in Jimma Zone, Ethiopia. Twenty-four clusters with 160 individuals each are required to detect a 17% change in the primary outcome (proportion of facility-based births) with 80% power,assuming a cluster autocorrelation of 0.8 and an intra-cluster correlation coefficient of 0.1. Primary health care units (PHCU) which consist of a health centre and several community-based health posts will serve as trial clusters. All PHCUs with maternity waiting areas (MWAs) constructed will be eligible for selection. Eligible women will be randomly selected from PHCU catchment areas stratified by MWA functionality and health centre basic emergency obstetric care (BEmOC) capacity. This is to ensure balanced distribution of poorly functioning MWAs and facilities with diminished BEmOC capacity between trial arms.
Cross-sectional household surveys will be conducted with eligible women to collect information on socio-demographics, knowledge, attitudes and practices regarding maternal health services, reproductive history and maternal health service utilization. Surveys will be administered by trained interviewers on tablet computers programmed using Open Data Kit at baseline prior to intervention roll out and at endline. Multilevel regression models will be used to quantify the effect of the intervention packages on outcomes of interest. Random effect terms for PHCUs will be included to account for the clustered nature of the data.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Women who were pregnant up to one year prior to the baseline survey and had a live birth, stillbirth or abortion (spontaneous or induced) and are residents in the study districts during the survey period are eligible to take part in the study.
Exclusion Criteria:
- Women who are not able to provide informed consent due to severe illness or mental health conditions.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Styre
|
|
|
Eksperimentell: MWA+IEC intervention
|
The MWA intervention will involve upgrading existing maternity waiting areas to ensure that essential supplies and services are available to create a comfortable environment for women to temporarily reside in and have easy access to skilled obstetric services.
Community and religious leaders will each attend one-day workshops designed using participatory, adult learning methods to help participants better understand the importance of maternal health care services, identify barriers to accessing care and to strategize how to promote utilization of services. Half-day workshops will conducted in subsequent years to build on shared experiences. Health extension workers will attend 3-day workshops to identify enablers and barriers to implementation of the safe motherhood components of the health extension program and strategize on how to engage community and religious leaders to support access to maternal health care services in their communities. Half-day workshops will conducted in subsequent years for each of the participant groups to build on shared experiences. |
|
Eksperimentell: IEC intervention
|
Community and religious leaders will each attend one-day workshops designed using participatory, adult learning methods to help participants better understand the importance of maternal health care services, identify barriers to accessing care and to strategize how to promote utilization of services. Half-day workshops will conducted in subsequent years to build on shared experiences. Health extension workers will attend 3-day workshops to identify enablers and barriers to implementation of the safe motherhood components of the health extension program and strategize on how to engage community and religious leaders to support access to maternal health care services in their communities. Half-day workshops will conducted in subsequent years for each of the participant groups to build on shared experiences. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Facility-based birth coverage
Tidsramme: Information on the primary outcome will be collected through surveys at baseline (prior to intervention roll out) and endline (approximately one and a half years after intervention roll out has commenced)
|
Proportion of women who report giving birth to their last child at a health facility (health centre or hospital) which has skilled birth attendants present (doctor, midwife, clinical nurse).
|
Information on the primary outcome will be collected through surveys at baseline (prior to intervention roll out) and endline (approximately one and a half years after intervention roll out has commenced)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Antenatal care coverage
Tidsramme: Information on secondary outcomes will be collected through surveys at baseline (prior to intervention roll out) and endline (approximately one and a half years after intervention roll out has commenced)
|
Proportion of women who report making at least one antenatal care visit to a health facility during their last pregnancy.
|
Information on secondary outcomes will be collected through surveys at baseline (prior to intervention roll out) and endline (approximately one and a half years after intervention roll out has commenced)
|
|
Postnatal care coverage
Tidsramme: Information on secondary outcomes will be collected through surveys at baseline (prior to intervention roll out) and endline (approximately one and a half years after intervention roll out has commenced)
|
Proportion of women who report receiving a checkup from a healthcare worker at least once during the 42 days after delivery of their last child.
|
Information on secondary outcomes will be collected through surveys at baseline (prior to intervention roll out) and endline (approximately one and a half years after intervention roll out has commenced)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Manisha Kulkarni, PhD, University of Ottawa
- Hovedetterforsker: Lakew Abebe, MPH, Jimma University
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Kurji J, Gebretsadik LA, Wordofa MA, Morankar S, Bedru KH, Bulcha G, Bergen N, Kiros G, Asefa Y, Asfaw S, Mamo A, Endale E, Thavorn K, Labonte R, Taljaard M, Kulkarni MA. Effectiveness of upgraded maternity waiting homes and local leader training on improving institutional births: a cluster-randomized controlled trial in Jimma, Ethiopia. BMC Public Health. 2020 Oct 22;20(1):1593. doi: 10.1186/s12889-020-09692-4.
- Kurji J, Kulkarni MA, Gebretsadik LA, Wordofa MA, Morankar S, Bedru KH, Bulcha G, Thavorn K, Labonte R, Taljaard M. Effectiveness of upgraded maternity waiting homes and local leader training in improving institutional births among women in the Jimma zone, Ethiopia: study protocol for a cluster-randomized controlled trial. Trials. 2019 Dec 4;20(1):671. doi: 10.1186/s13063-019-3755-z.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 108028-002
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Mødredødelighet
-
Forman Christian College, PakistanUNICEFRekrutteringMors helse | Maternal Health LiteracyPakistan
-
University Hospital, Basel, SwitzerlandFullførtMaternal hemodynamisk stabilitetSveits
-
National Human Genome Research Institute (NHGRI)National Cancer Institute (NCI)Rekruttering
-
Ain Shams UniversityFullførtMaternal Diabetes Mellites Effekt på fosteretEgypt
-
Yale UniversityNational Institute on Drug Abuse (NIDA)FullførtMaternal stoffbruk | Barnemishandling og omsorgssviktForente stater
-
Mongi Slim HospitalUkjentKeisersnitt | Maternal hypotensjonssyndrom
-
Medical University of ViennaFullførtMitokondrielt DNA | Epidural-relatert maternal feber (ERMF)Østerrike
-
Hawassa UniversityNestlé FoundationHar ikke rekruttert ennåMors; Underernæring, påvirker fosteret | Maternal anemi under graviditet, før fødsel
-
MetroHealth Medical CenterFullførtFoster eller nyfødt påvirket av maternal epidural anestesi under fødsel og fødselForente stater
-
University of JordanFullført
Kliniske studier på MWA intervention
-
Shanghai Chest HospitalUkjent
-
Henan Provincial People's HospitalHar ikke rekruttert ennå
-
The University of Hong KongRekrutteringGraves 'sykdom | Minimalt invasiv behandling | AblasjonsbehandlingHong Kong
-
National Taiwan University HospitalRekrutteringSolid svulst inkludert skjoldbruskkjertel, bein, lever, bukspyttkjertelTaiwan
-
University of Wisconsin, MadisonAvsluttetKarsinom, nyrecelleForente stater
-
Chinese PLA General HospitalFullførtHepatocellulært karsinomKina
-
Shanghai Chest HospitalShanghai Allist Pharmaceuticals Co.,Ltd.Har ikke rekruttert ennå
-
Rigshospitalet, DenmarkAktiv, ikke rekrutterendeLevermetastaser | Kolorektal karsinomDanmark
-
Jihad Hussien Mohamed MahmoudHar ikke rekruttert ennåLivmorfibrom (Leiomyom) | Symptomatisk Uterin LeiomyomEgypt
-
Shandong Provincial HospitalAktiv, ikke rekrutterendeTidlig hepatocellulært karsinomKina